Start Date
January 31, 2024
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2029
UKidney
The intended clinical product is a kidney derived from a domestic pig that contains an intentional genomic alteration (IGA) to protect it after transplantation from the human immune response via inactivation of endogenous porcine genes responsible for expression of pig epitopes and inclusion of human transgenes to inhibit host immunogenic response.
University of Alabama Birmingham, Birmingham
Collaborators (2)
United Therapeutics
INDUSTRY
Lung Biotechnology PBC
INDUSTRY
University of Alabama at Birmingham
OTHER